← Back to Search

Retail Environments for Tobacco Smoking

N/A

Recruiting

Led By Emily Falk, PhD

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between the ages of 21-65

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]

Awards & highlights

Study Summary

This trial looks at how smoking affects the brain and behavior, as well as exposure to smoking in specific environments.

Who is the study for?

This study is for English-speaking smokers aged 21-65 who smoke at least 5 cigarettes daily for the past 6 months. Participants must own a smartphone, be fully vaccinated against COVID-19, and reside in PA, DE, NJ or the Philadelphia area for the next 3 months with limited absences.Check my eligibility

What is being tested?

The trial aims to understand how smokers' brains and behaviors are influenced by their everyday environments, particularly retail spaces like convenience stores (7-11) and pharmacies (CVS).See study design

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 21 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)]

This trial's timeline: 3 weeks for screening, Varies for treatment, and for 822815, fmri scan day 1 (at least 2 weeks after initial enrollment); for 850796, fmri scan 1 (at least 6 weeks after initial enrollment)] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Brain activity (measured by functional magnetic resonance imaging), in a priori regions of interest, in response to smoking vs nonsmoking cues (all 822815 participants and fMRI subset of 850796 participants)

Neural cue reactivity region definition (822815 participants and fMRI subset of 850796 participants)

Self-reported cigarette craving during the experimental manipulation period

+1 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: CVS GroupExperimental Treatment1 Intervention

Participants visit CVS 5 times per week during the 4-week (20 store visits total) intervention period

Group II: 7-11 GroupExperimental Treatment1 Intervention

Participants visit 7-11 5 times per week during the 4-week (20 store visits total) intervention period

Group III: ControlActive Control1 Intervention

Participants are not asked to alter their behavior during the 4-week (0 store visits) intervention period

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

145,354 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,666 Previous Clinical Trials

40,925,695 Total Patients Enrolled

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,881,899 Total Patients Enrolled

Media Library

CVS Clinical Trial Eligibility Overview. Trial Name: NCT04279483 — N/A

Tobacco Smoking Research Study Groups: CVS Group, 7-11 Group, Control

Tobacco Smoking Clinical Trial 2023: CVS Highlights & Side Effects. Trial Name: NCT04279483 — N/A

CVS 2023 Treatment Timeline for Medical Study. Trial Name: NCT04279483 — N/A

Tobacco Smoking Patient Testimony for trial: Trial Name: NCT04279483 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age limit for enrolling in this experiment over 30 years old?

"This study has an age requirement of over 21 and under 65 years old for potential participants."

Answered by AI

Are there any openings for participants in this clinical experiment presently?

"Confirmed - the clinicaltrial.gov registry reveals that this trial is still seeking participants, with its initial posting occurring on December 17th 2019 and last revision taking place on July 26th 2022."

Answered by AI

How many people have been recruited for participation in this clinical trial?

"Affirmative. The information posted on clinicaltrials.gov demonstrates that this medical trial is actively recruiting patients - it was initially listed on December 17th 2019 and the data has been recently updated as of July 26th 2022. 180 participants are needed from a single site to complete the study."

Answered by AI

Could I potentially join this research effort?

"This study is actively seeking 180 participants who are between 21 and 65 years old, have smoked cigarettes on a daily basis for the past half year, own an iPhone or Android device which can be used regularly, live in Pennsylvania, Delaware or New jersey (for remote studies) or within Philadelphia's metropolitan area (for fMRI trials), possess fluency in English language, have been fully vaccinated against COVID-19 and still smoke."

Answered by AI

Who else is applying?

What state do they live in?

New Jersey

Pennsylvania

How old are they?

18 - 65

What site did they apply to?

University of Pennsylvania

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

Tired of smoking and feeling depressed. Been waiting to find a way to stop smoking.

PatientReceived no prior treatments

IT'S NECESSARY SOMETHING I SHOULD DONE LONG AGO. Simple really it's a nasty habit and makes your breath bad and it's hard to breathe do it because I get stressed.

PatientReceived 1 prior treatment